2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
2012 - Europe Direct Iasi
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Description<br />
EUROINVENT <strong>2012</strong><br />
Material Science Department<br />
The state of art of prosthetics for partial foot amputation have the<br />
big deficit of an predefine strength and a height difference<br />
between ground and the stump because of intermediate parts.<br />
My project is about a modular lamellar system with a low profile<br />
that can be upgrade according to strength necessity.<br />
X. 24.<br />
Innovative research approaches of S.C. Biotehnos SA in<br />
Title<br />
cosmetic and pharmaceutical industry<br />
Authors Laura Olariu, Emilia Buse<br />
Institution SC BIOTEHNOS SA<br />
Biotehnos research infrastructure was developed with financial<br />
help from POS CCE 74/04.09.2009 ID 275 SMIS-CSNR 2801<br />
which enhancing its dermatocosmetical and pharmaceutical<br />
research capacity through organization of three new research<br />
laboratories ( Biotechnological Research, Chromatography and<br />
Bioanalytical studies and Topic Conditioned Products) and<br />
upgrading Bioactive Extracts Sector with equipments of higher<br />
standards thus completing the own research system of<br />
interrelation concept → applications ↔ optimization →<br />
capitalization. This provides the functionality of an innovative<br />
research algorithm between rigorous quality control of<br />
biological materials, then obtaining technologies of superior<br />
physical-chemical characterizated actives principles and proving<br />
of specific biological actions by deeper researches at molecular<br />
and cellular level that supporting in vivo effects which are valued<br />
Description<br />
by an efficient product formulations.<br />
We implemented an efficient system of innovative processes and<br />
products development starting with quantification of toxic<br />
residues (pesticides and heavy metals) from biological materials<br />
by validated gas chromatography, AAS and LC-MS methods<br />
follow up by own in vitro analyses of toxicity and specific<br />
biological activity as well as in vivo extrapolation of significant<br />
target actions. First in our country, we perform state of the art<br />
researches of specific gene expression by qPCR for the genomic<br />
approach in early and deep assessing of efficacy and in vitro/ ex<br />
vivo studies of penetration and dermal absorption of actives<br />
topics by Franz diffusion for proving in vivo effects that<br />
represent the cutting edge of cosmetic and pharmaceutical<br />
science.<br />
We performed all stages of researches according of bioproduct<br />
quality and safety standards of UE legislations.<br />
Innovative Researches<br />
180